e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: cardiovascular comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
G. Baimakanova, S. Avdeev, P. Zubairova, A. Chuchalin, K. Zykov, G. Tkachov (Moscow, Russian Federation)
Source:
Annual Congress 2010 - COPD: cardiovascular comorbidities
Session:
COPD: cardiovascular comorbidities
Session type:
E-Communication Session
Number:
5216
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Baimakanova, S. Avdeev, P. Zubairova, A. Chuchalin, K. Zykov, G. Tkachov (Moscow, Russian Federation). B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF). Eur Respir J 2010; 36: Suppl. 54, 5216
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006
Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration
Source: Eur Respir J 2004; 24: Suppl. 48, 563s
Year: 2004
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 279s
Year: 2004
Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF)
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction
Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management
Year: 2006
Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007
N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept